-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Summary: Agios Pharmaceuticals Q4

Benzinga·02/12/2026 11:36:07
Listen to the news

The earnings results for Agios Pharmaceuticals (NASDAQ:AGIO) for Q4 were made public on Thursday, February 12, 2026 at 06:31 AM.

Here's a comprehensive overview of the announcement.

Earnings

Agios Pharmaceuticals beat estimated earnings by 5.1%, reporting an EPS of $-1.86 versus an estimate of $-1.96.

Revenue was up $9.27 million from the same period last year.

Performance in Previous Earnings

During the previous quarter, the company beat on EPS by $0.14, leading to a 0.14% increase share price change the next day.

Here's a look at Agios Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -1.92 -1.77 -1.76 -1.63
EPS Actual -1.78 -1.93 -1.55 -1.94
Revenue Estimate 10.40M 9.36M 9.68M 9.35M
Revenue Actual 12.88M 12.46M 8.73M 10.70M

To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.